DIAPRIDE MS2 TAB

About

DIAPRIDE MS2 TAB combines glimepiride, a sulfonylurea, with metformin, a biguanide, to offer a synergistic approach for the management of type 2 diabetes mellitus in adults. Glimepiride primarily acts by stimulating the beta cells of the pancreas to release more insulin, thereby lowering blood glucose levels. Its effectiveness is contingent upon the presence of functioning pancreatic beta cells.

Metformin works through multiple mechanisms: it significantly reduces glucose production by the liver, decreases the absorption of glucose from the gastrointestinal tract, and enhances insulin sensitivity in peripheral tissues, allowing the body's own insulin to work more effectively. This combination therapy addresses both impaired insulin secretion and insulin resistance, providing robust and comprehensive glycemic control when diet and exercise alone are insufficient to achieve target blood sugar levels.

Uses

• Management of type 2 diabetes mellitus in adults.
• To improve glycemic control as an adjunct to diet and exercise.
• For patients inadequately controlled on glimepiride or metformin alone.
• To reduce fasting and postprandial blood glucose levels.

Directions For Use

Take orally with meals, usually once or twice daily, as prescribed by your healthcare provider. Swallow the tablet whole with water.

Benefits

• Effective reduction in blood glucose and HbA1c.
• Improved insulin secretion from the pancreas.
• Reduced hepatic glucose production.
• Enhanced insulin sensitivity in peripheral tissues.
• Dual mechanism of action for comprehensive control.
• Convenient combination therapy.

Side Effects

• Hypoglycemia (low blood sugar)
• Nausea and vomiting
• Diarrhea or abdominal discomfort
• Headache
• Dizziness
• Weight gain (associated with glimepiride)
• Lactic acidosis (rare, but serious with metformin)
• Metallic taste in mouth
• Skin rash or allergic reactions
• Vitamin B12 deficiency (with long-term metformin use)
• Anemia
• Upper respiratory tract infection

Safety Measures

• Alcohol - Avoid excessive alcohol intake as it can increase the risk of hypoglycemia with glimepiride and lactic acidosis with metformin.
• Pregnancy - Not recommended during pregnancy due to potential risks to the fetus, including neonatal hypoglycemia. Consult a doctor.
• Breastfeeding - Avoid during breastfeeding as components may pass into breast milk and cause hypoglycemia in the infant. Seek medical advice.
• Liver - Use with caution in patients with liver impairment; metformin is contraindicated in severe hepatic dysfunction due to increased risk of lactic acidosis. Glimepiride metabolism may be affected.
• Kidney - Contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m²). Dosage adjustment is required for moderate impairment due to metformin and glimepiride excretion.
• Lung - No specific contraindications related to lung conditions, but severe respiratory failure can increase lactic acidosis risk.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.